[1] |
PAIETTA E, RACEVSKIS J, BENNETT J M, et al. Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology:the Eastern Cooperative Oncology Group experience[J]. Leukemia, 1998, 12(12):1881-1885.
DOI
URL
|
[2] |
KEUNG Y K, BEATY M, POWELL B L, et al. Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia-retrospective study and review of literature[J]. Leuk Res, 2004, 28(6):579-586.
DOI
URL
|
[3] |
KONOPLEV S, YIN C C, KORNBLAU S M, et al. Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia[J]. Leuk Lymphoma, 2013, 54(1):138-144.
DOI
URL
|
[4] |
SOUPIR C P, VERGILIO J A, DAL CIN P, et al. Philadelphia chromosome-positive acute myeloid leukemia:a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis[J]. Am J Clin Pathol, 2007, 127(4):642-650.
DOI
URL
|
[5] |
BEITINJANEH A, JANG S, ROUKOZ H, et al. Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia:a systematic review[J]. Leuk Res, 2010, 34(7):831-836.
DOI
URL
|
[6] |
SANTOS F P, JONES D, QIAO W, et al. Prognostic value of FLT3 mutations among different cytogenetic subgroups in acute myeloid leukemia[J]. Cancer, 2011, 117(10):2145-2155.
DOI
URL
|
[7] |
WANG K, ZHOU F, CAI X, et al. Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation[J]. Hematology, 2020, 25(1):211-218.
DOI
URL
|
[8] |
江凤, 王元元, 陈子兴, 等. 伴有费城染色体和inv(16) 阳性的原发性急性髓系白血病的临床及实验室特征[J]. 中国实验血液学杂志, 2015, 23(2):335-339.
|
[9] |
王小蕊, 赵初娴, 秦尤文, 等. 费城染色体阳性急性髓系白血病3例[J]. 内科理论与实践, 2018, 13(2):115-117.
|
[10] |
PATNAIK M M. The importance of FLT3 mutational analysis in acute myeloid leukemia[J]. Leuk Lymphoma, 2018, 59(10):2273-2286.
DOI
URL
|
[11] |
NEUENDORFF N R, BURMEISTER T, DÖRKEN B, et al. BCR-ABL-positive acute myeloid leukemia:a new entity? Analysis of clinical and molecular features[J]. Ann Hematol, 2016, 95(8):1211-1221.
DOI
URL
|
[12] |
YIP S F, WAN T S, LIU H S, et al. Philadelphia chromosome unmasked as a secondary genetic change in acute myeloid leukemia on imatinib treatment[J]. Leukemia, 2006, 20(11):2050-2051.
DOI
URL
|
[13] |
ITO K, TOMINAGA K, SUZUKI T, et al. Successful treatment with imatinib mesylate in a case of minor BCR-ABL-positive acute myelogenous leukemia[J]. Int J Hematol, 2005, 81(3):242-245.
DOI
URL
|
[14] |
PAPAGEORGIOU S G, PAPPA V, ECONOMOPOULOU C, et al. Dasatinib induces long-term remission in imatinib-resistant Philadelphia chromosome-positive acute megakaryoblastic leukemia but fails to prevent development of central nervous system progression[J]. Leuk Res, 2010, 34(9):e254-e256.
DOI
URL
|